Jakarta, 19 November 2021, PT Central Proteina Prima Tbk, again held its annual routine event, namely the “Annual General Meeting of Shareholders (GMS), and Extraordinary General Meeting of Shareholders (EGMS) which were held at Soehana Hall SCBD Building, Jakarta. The agenda for the meeting this time was held in person and virtual zoom because it was still in a state of the covid-19 pandemic. This GMS & EGMS were attended by the shareholders and the entire Board of Directors of CP Prima.
The agenda for this annual general meeting of shareholders is as follows:
- Granting dispensation to the Company for the delay in holding the General Meeting The Company's Annual Shareholders for the financial year ending on the 31st (thirtyone) December 2020 (two thousand and twenty).
- Approval of the Company's Annual Report and Ratification of the annual Financial Statements the Company for the financial year 2020 (two thousand and twenty) as well as granting exemptions and full settlement (acquiet et de charge) to the Board of Directors and the Board of Commissioners of the Company.
- Appointment of a Public Accounting Firm that will audit the financial statements the Company for the fiscal year 2021 (two thousand and twenty one) and other periods within the fiscal year 2021 (if needed), as well as to determine the honorarium of the Public Accountant and other requirements.
- Approval to authorize the Company's Board of Commissioners to determine: the amount of remuneration and/or other benefits for members of the Board of Directors and Board of Commissioners of the Company for the fiscal year 2021 (two thousand twenty one).
Agenda of the Extraordinary General Meeting of Shareholders:
- Approval of amendments to the Company's articles of association to change the term of office of the Commissioners Company.